Effects of salmeterol on host resistance to Trichinella spiralis in rats

International Journal of Immunopharmacology

Volumn 21, Issue 8, 1999, Pages 523-529

  De Waal, E J ^a   De Jong, W H ^a   Van Der Stappen, A J ^a   Verlaan, B ^a   Van Loveren, H ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Host resistance; Rat; Salmeterol; Trichinella spiralis

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN M; SALMETEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL INFECTION; HISTOPATHOLOGY; HOST RESISTANCE; IMMUNOTOXICITY; INFLAMMATION; LARVA; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; TONGUE; TRICHINELLA SPIRALIS;

ADRENERGIC BETA-AGONISTS; ALBUTEROL; ANIMALS; ANTIBODIES, HELMINTH; ANTIBODY SPECIFICITY; IMMUNITY, NATURAL; MALE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA-2; TONGUE; TRICHINELLA SPIRALIS; TRICHINOSIS;

EID: 0032971673     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(99)00030-2     Document Type: Article

References (12)

1. Baker A.J., Palmer J., Johnson M., Fuller R.W. Inhibitory action of salmeterol on human airway macrophages and blood monocytes. Eur. J. Pharmac. 264:1994;301-306.
2. 2-adrenoreceptor agonist: characterization of pharmacological activity in vitro and in vivo. Br. J. Pharmac. 104:1991;665-671.
3. De Waal E.J., de Jong W.H., van der Vliet H., Verlaan B., van Loveren H. An immunotoxicity screening study on salmeterol in rats. Int. J. Immunopharmac. 18:1996;523-528.
4. Butchers P.R., Vardey C.J., Johnson M. Salmeterol: a potent and long-acting inhibitor of inflammatory release from human lung. Br. J. Pharmaoc. 104:1991;672-676.
5. Ezeamuzie C.I., Al-Hage M., Nwankwoala R.N.P. The effect of salmeterol on human eosinophils is both stimulus- and response-dependent. Int. J. Immunopharmac. 19:1997;421-430.
6. Jack D. The 1990 Lilly prize lecture. A way of looking at agonism and antagonism: lessons from salbutamol, salmeterol and other β-adrenoreceptor agonists. Br. J. Clin. Pharmac. 31:1991;501-514.
7. 2-adreno-receptor agonists on mast cells of rat, guinea pig, and human. Int. Arch. Allergy Immun. 105:1994;177-180.
8. Rabe K.F., Chung K.F. The challenge of long-acting β-adrenoreceptor agonists. Respir. Med. 85:1991;5-9.
9. 2-adrenoreceptor agonist in guinea pig skin. Eur. J. Pharmac. 272:1995;185-193.
10. Van Loveren H., Luebke R.W., Vos J.G. Assessment of immunotoxicity with the parasitic infection model Trichinella spiralis. Burleson G.R., Dean J.H., Muuson A.E. Methods in immunotoxicology. vol. 2:1995;243-271 Wiley-Liss Inc, New York.
11. Whelan C.J., Johnson M. Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin. Br. J. Pharmac. 105:1992;831-838.
12. Whelan C.J., Johnson M., Vardey C.J. Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung. Br. J. Pharmac. 110:1993;613-618.